Next, we evaluated whether the CTNNBIP1 expression was related to changes in the expression of various β-catenin-targeted genes, such as MMP7, cyclin D1, and c-MYC, among these lung cancer patients. The gene discussed is CTNNBIP1; the disease is lung cancer.